ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Non-Current Assets data on file, last reported at $2.9 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $2.9 million, up 192.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (down 16.36% YoY), and the FY2025 annual result was $2.9 million, up 183.29% from the prior year.
• Non-Current Assets improved to $2.9 million in Q1 2026 per NDRA's latest filing, from $2.9 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $3.9 million in Q4 2022 and troughed at $778054.0 in Q3 2022.
• A 5-year average of $2.0 million and a median of $1.2 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 398.99% in 2022, then slumped 74.4% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $3.9 million in 2022, then decreased by 4.45% to $3.7 million in 2023, then tumbled by 72.63% to $1.0 million in 2024, then surged by 183.29% to $2.9 million in 2025, then gained by 0.54% to $2.9 million in 2026.
• Business Quant data shows NDRA's Non-Current Assets at $2.9 million in Q1 2026, $2.9 million in Q4 2025, and $915399.0 in Q3 2025.